Brief: Vitrafy Life Sciences Enters Strategic Commercial Agreement With IMV Technologies
15/01/2026 03:54
Jan 15 (Reuters) - Vitrafy Life Sciences Ltd VFY.AX: VITRAFY ENTERS STRATEGIC COMMERCIAL AGREEMENT WITH IMV TECHNOLOGIES PARTNERSHIP IS DESIGNED TO INTEGRATE CO'S CRYOPRESERVATION TECHNOLOGY WITH IMV'S GLOBALLY RECOGNISED OFFERING Further company coverage: VFY.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vitrafy Life Sciences
See all newsAustralia's Vitrafy Life Sciences slumps on discounted placement
Brief: Vitrafy Life Sciences Receives Firm Commitments For A$30 Million Placement
Brief: Vitrafy Life Sciences Seeks Trading Halt
Brief: Vitrafy Life Sciences Enters Partnership With Vitalant Innovation Center
Brief: Vitrafy Life Sciences Posts HY Loss After Tax A$7.1 Million